Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
2000
Background: Parenteral iron therapy is required in a majority of chronic dialysis patients who are receiving recombinant human erythropoietin (r-HuEPO) in order to provide adequate
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
54
Citations
NaN
KQI